SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, will present at
the Barclays Global Healthcare Conference on March 10 and the H.C. Wainwright Global Life
Sciences Conference on March 9-10.
Dr. Richard Chin, Chief Executive
Officer, will be available for one-on-one meetings. During this
time, investors will have the opportunity to discuss recent
developments, study results from key therapeutic programs in
development, and upcoming milestones.
Conference Details:
Barclays Global Healthcare Conference
Date: March 10, 2021
Presentation time: 2:25 – 2.50p.m.
ET, Virtual Track 3
Webcast URL: Click here
H.C. Wainwright Global Life Sciences Conference
Date: March 9-10, 2021
Presentation time: On demand access beginning March 9
Webcast URL: Click here
An archived version of the above webcasts will be available for
30 days on the KindredBio website.
About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing
innovative biologics focused on saving and improving the lives of
pets. Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The Company's
strategy is to identify targets that have already demonstrated
safety and efficacy in humans and to develop therapeutics based on
these validated targets for dogs and cats. KindredBio has a deep
pipeline of novel biologics in development across many therapeutic
classes, alongside state-of-the-art biologics manufacturing
capabilities and a broad intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download
multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-barclays-global-healthcare-conference-and-hc-wainwright-global-life-sciences-conference-301238002.html
SOURCE Kindred Biosciences, Inc.